Nuvaring and Conversion disorder - a phase IV clinical study of FDA data

Summary:

Conversion disorder is reported as a side effect among people who take Nuvaring (ethinyl estradiol; etonogestrel), especially for people who are female, 20-29 old, have been taking the drug for 1 - 6 months also take Valtrex, and have Ovarian cysts.

The phase IV clinical study analyzes which people have Conversion disorder when taking Nuvaring. It is created by eHealthMe based on reports of 27,664 people who have side effects when taking Nuvaring from the FDA, and is updated regularly.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,730 Nuvaring users. Check the latest studies of Nuvaring.

What is Conversion disorder?

Conversion disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause) is found to be associated with 296 drugs and 600 conditions by eHealthMe. Check the latest studies of Conversion disorder.

On Apr, 24, 2026

27,664 people reported to have side effects when taking Nuvaring.
Among them, 19 people (0.07%) have Conversion disorder.

Could Nuvaring cause Conversion disorder?

Among these 19 people:

How long have people been on Nuvaring when they have Conversion disorder? *

What is the gender of people who have Conversion disorder when taking Nuvaring? *

female: 100 %
male: 0.0 %

What is the age of people who have Conversion disorder when taking Nuvaring? *

What are other drugs people take besides Nuvaring? *

Ventolin: 6 people, 31.58%
Valtrex: 6 people, 31.58%
Tramadol Hydrochloride And Acetaminophen: 5 people, 26.32%
Fioricet: 5 people, 26.32%
Synthroid: 2 people, 10.53%
Hydrochlorothiazide: 2 people, 10.53%
Xanax: 1 person, 5.26%
Vitamin D: 1 person, 5.26%
Tysabri: 1 person, 5.26%
Paraplatin: 1 person, 5.26%

What are other side effects people have besides Conversion disorder? *

Migraine (headache): 12 people, 63.16%
Stress And Anxiety: 12 people, 63.16%
Speech Impairment (Adult) (inability to speak (adult)): 11 people, 57.89%
Hemiparesis (weakness on one side of the body): 10 people, 52.63%
Vocal Cord Disorder: 9 people, 47.37%
Vision Blurred: 9 people, 47.37%
Nausea (feeling of having an urge to vomit): 9 people, 47.37%
Pulmonary Embolism (blockage of the main artery of the lung): 9 people, 47.37%
Nausea And Vomiting: 8 people, 42.11%
Asthma: 8 people, 42.11%

What are the existing conditions these people have? *

Ovarian Cysts (fluid filled sacs of the ovary): 2 people, 10.53%
Toothaches (tooth pain): 1 person, 5.26%
Pain: 1 person, 5.26%
Nausea (feeling of having an urge to vomit): 1 person, 5.26%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.26%
Migraine (headache): 1 person, 5.26%
Menstrual Disorder (disease of menstrual cycle): 1 person, 5.26%
Lung Cancer - Small Cell (lung cancer): 1 person, 5.26%
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain): 1 person, 5.26%
Depression: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Nuvaring and have Conversion disorder?

- Check whether Conversion disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nuvaring:

Nuvaring (28,730 reports)

Conversion disorder treatments and more:

Conversion disorder (2,815 reports)

How severe was Conversion disorder and when was it recovered:

Conversion disorder in Nuvaring

Expand to all the drugs that have ingredients of ethinyl estradiol; etonogestrel:

Conversion disorder and drugs with ingredients of ethinyl estradiol; etonogestrel

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conversion disorder:

Conversion disorder (296 drugs)

Browse all the conditions that are associated with Conversion disorder:

Conversion disorder (600 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; etonogestrel (the active ingredients of Nuvaring) and Nuvaring (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.